Color vision impairments in schizophrenia and the role of antipsychotic medication type

Schizophrenia patients (SCZ) demonstrate deficits in many domains of mental functioning, including visual perception. An issue that has been relatively unexplored, in terms of explaining variation in visual function in SCZ, however, is medication use. The present study explored potential medication effects on color vision in SCZ, a process that is strongly linked to dopaminergic function in the retina. SCZ patients who had clear-cut either typical (n  = 29) or atypical (n = 29) monotherapy, without any other concurrent medication, and a group of age- and gender-matched healthy controls participated in the study.

Source: Schizophrenia Research - September 7, 2018 Category: Psychiatry Authors: Thiago Monteiro Paiva Fernandes, Steven M. Silverstein, Pamela D. Butler, Szabolcs K éri, Lucas Galdino Santos, Renata Lyra Nogueira, Natanael Antonio Santos Source Type: research